InvestorsHub Logo
Followers 22
Posts 1570
Boards Moderated 0
Alias Born 01/17/2019

Re: MontanaState83 post# 241782

Thursday, 01/16/2020 10:23:51 PM

Thursday, January 16, 2020 10:23:51 PM

Post# of 425961
Cannot be 100% until it's brought up in trial. However, there are three options that I can think of:

1) Amarin's presentation
- Dated "January 14, 2020"
- Contained no new substantial information.
- Why would Amarin be submitting this as "evidence"?

2) DRL's presentation
- Dated "14th January 2020"
- Does not discuss EPA / Vascepa / financial numbers

3) Hikma's presentation
- Dated "January 2020" (matches docket)
- Discusses market share for their generic of Vascepa
- Discusses the trial

4) Other
- Can't think of any but maybe you can.

If I were a betting man, I would put the whole neighborhood on 3).
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News